BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Karpiński TM, Adamczak A. Anticancer Activity of Bacterial Proteins and Peptides. Pharmaceutics 2018;10:E54. [PMID: 29710857 DOI: 10.3390/pharmaceutics10020054] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 13.3] [Reference Citation Analysis]
Number Citing Articles
1 Marković KG, Grujović MŽ, Koraćević MG, Nikodijević DD, Milutinović MG, Semedo-Lemsaddek T, Djilas MD. Colicins and Microcins Produced by Enterobacteriaceae: Characterization, Mode of Action, and Putative Applications. Int J Environ Res Public Health 2022;19:11825. [PMID: 36142096 DOI: 10.3390/ijerph191811825] [Reference Citation Analysis]
2 Koo DJ, Sut TN, Tan SW, Yoon BK, Jackman JA. Biophysical Characterization of LTX-315 Anticancer Peptide Interactions with Model Membrane Platforms: Effect of Membrane Surface Charge. IJMS 2022;23:10558. [DOI: 10.3390/ijms231810558] [Reference Citation Analysis]
3 Dicks LMT, Vermeulen W. Do Bacteria Provide an Alternative to Cancer Treatment and What Role Does Lactic Acid Bacteria Play? Microorganisms 2022;10:1733. [DOI: 10.3390/microorganisms10091733] [Reference Citation Analysis]
4 Singh N, Tapader R, Chatterjee S, Pal A, Pal A. Subtilisin from Bacillus amyloliquefaciens induces apoptosis in breast cancer cells through ubiquitin-proteasome-mediated tubulin degradation. Int J Biol Macromol 2022;220:852-65. [PMID: 35985398 DOI: 10.1016/j.ijbiomac.2022.08.086] [Reference Citation Analysis]
5 Haider T, Pandey V, Behera C, Kumar P, Gupta PN, Soni V. Nisin and nisin-loaded nanoparticles: a cytotoxicity investigation. Drug Dev Ind Pharm 2022;:1-42. [PMID: 35938875 DOI: 10.1080/03639045.2022.2111438] [Reference Citation Analysis]
6 Zhou H, Huang R, Su T, Li B, Zhou H, Ren J, Li Z. A c-MWCNTs/AuNPs-based electrochemical cytosensor to evaluate the anticancer activity of pinoresinol from Cinnamomum camphora against HeLa cells. Bioelectrochemistry 2022;146:108133. [DOI: 10.1016/j.bioelechem.2022.108133] [Reference Citation Analysis]
7 Ramadhani D, Maharani R, Gazzali AM, Muchtaridi M. Cyclic Peptides for the Treatment of Cancers: A Review. Molecules 2022;27:4428. [DOI: 10.3390/molecules27144428] [Reference Citation Analysis]
8 Sadrekarimi H, Gardanova ZR, Bakhshesh M, Ebrahimzadeh F, Yaseri AF, Thangavelu L, Hasanpoor Z, Zadeh FA, Kahrizi MS. Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03492-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Susmi TF, Rahman Khan MM, Rahman A, Mahmud S, Saleh MA, Reza MA, Rahi MS. In vitro antioxidant and cytotoxicity activities and in silico anticancer property of methanolic leaf extract of Leucas indica. Informatics in Medicine Unlocked 2022. [DOI: 10.1016/j.imu.2022.100963] [Reference Citation Analysis]
10 Bao Y, Cheng Y, Liu W, Luo W, Zhou P, Qian D. Bacteria−Based Synergistic Therapy in the Backdrop of Synthetic Biology. Front Oncol 2022;12:845346. [DOI: 10.3389/fonc.2022.845346] [Reference Citation Analysis]
11 Mueller A, Brockmueller A, Fahimi N, Ghotbi T, Hashemi S, Sadri S, Khorshidi N, Kunnumakkara AB, Shakibaei M. Bacteria-Mediated Modulatory Strategies for Colorectal Cancer Treatment. Biomedicines 2022;10:832. [DOI: 10.3390/biomedicines10040832] [Reference Citation Analysis]
12 Vijayakumar M, Priya K, Tharmalingam N, Bose RJC, Madheswaran T, Ramasamy M. Bacteria therapeutics for cancer oncology: a crossroads for new paradigms. Drug Discov Today 2022:S1359-6446(22)00115-5. [PMID: 35304339 DOI: 10.1016/j.drudis.2022.03.007] [Reference Citation Analysis]
13 Bandopadhyay N, Paramanik K, Kumar Mudi P, Sarkar G, Kotakonda M, Shit M, Biswas B, Sankar Das H. A thiomethyl-substituted imidazolyl imine functionalized copper(II) complex: synthesis, structural characterization, phenoxazinone synthase mimics and biological activities. Polyhedron 2022. [DOI: 10.1016/j.poly.2022.115783] [Reference Citation Analysis]
14 Ma Y, Qu R, Zhang Y, Jiang C, Zhang Z, Fu W. Progress in the Study of Colorectal Cancer Caused by Altered Gut Microbiota After Cholecystectomy. Front Endocrinol 2022;13:815999. [DOI: 10.3389/fendo.2022.815999] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Sharma A, Mehta V, Rani S, Noda M, Sugiyama M, Chander H, Kaur B. Biomedical applications of L-alanine produced by Pediococcus acidilactici BD16 (alaD+). Appl Microbiol Biotechnol 2022. [PMID: 35089399 DOI: 10.1007/s00253-022-11766-9] [Reference Citation Analysis]
16 Bhalla P, Rengaswamy R, Karunagaran D, Suraishkumar GK, Sahoo S. Metabolic modeling of host-microbe interactions for therapeutics in colorectal cancer. NPJ Syst Biol Appl 2022;8:1. [PMID: 35046399 DOI: 10.1038/s41540-021-00210-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
17 Garbacz K. Anticancer activity of lactic acid bacteria. Semin Cancer Biol 2022:S1044-579X(21)00306-0. [PMID: 34995799 DOI: 10.1016/j.semcancer.2021.12.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Sankarapandian V, Venmathi Maran BA, Rajendran RL, Jogalekar MP, Gurunagarajan S, Krishnamoorthy R, Gangadaran P, Ahn BC. An Update on the Effectiveness of Probiotics in the Prevention and Treatment of Cancer. Life (Basel) 2022;12:59. [PMID: 35054452 DOI: 10.3390/life12010059] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
19 Gammuto L, Chiellini C, Iozzo M, Fani R, Petroni G. The Azurin Coding Gene: Origin and Phylogenetic Distribution. Microorganisms 2021;10:9. [PMID: 35056457 DOI: 10.3390/microorganisms10010009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Karpiński TM. Evidence is insufficient to suggest that probiotics may reduce the risk of oral cancer. J Evid Based Dent Pract 2021;21:101637. [PMID: 34922715 DOI: 10.1016/j.jebdp.2021.101637] [Reference Citation Analysis]
21 Trivanović D, Pavelić K, Peršurić Ž. Fighting Cancer with Bacteria and Their Toxins. Int J Mol Sci 2021;22:12980. [PMID: 34884780 DOI: 10.3390/ijms222312980] [Reference Citation Analysis]
22 Hazrati F, Saidijam M, Ahmadyousefi Y, Nouri F, Ghadimipour H, Moradi M, Haddadi R, Soleimani M. A novel chimeric protein with enhanced cytotoxic effects on breast cancer in vitro and in vivo. Proteins 2021. [PMID: 34812523 DOI: 10.1002/prot.26285] [Reference Citation Analysis]
23 Shurpik DN, Aleksandrova YI, Mostovaya OA, Nazmutdinova VA, Zelenikhin PV, Subakaeva EV, Mukhametzyanov TA, Cragg PJ, Stoikov II. Water-soluble pillar[5]arene sulfo-derivatives self-assemble into biocompatible nanosystems to stabilize therapeutic proteins. Bioorg Chem 2021;117:105415. [PMID: 34673453 DOI: 10.1016/j.bioorg.2021.105415] [Reference Citation Analysis]
24 Lin D, Feng X, Mai B, Li X, Wang F, Liu J, Liu X, Zhang K, Wang X. Bacterial-based cancer therapy: An emerging toolbox for targeted drug/gene delivery. Biomaterials 2021;277:121124. [PMID: 34534860 DOI: 10.1016/j.biomaterials.2021.121124] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Acharya M, Kim T, Li C. Broad-Spectrum Antibiotic Use and Disease Progression in Early-Stage Melanoma Patients: A Retrospective Cohort Study. Cancers (Basel) 2021;13:4367. [PMID: 34503177 DOI: 10.3390/cancers13174367] [Reference Citation Analysis]
26 Karami K, Anbari K. Breast Cancer: A Review of Risk Factors and New Insights into Treatment. CCTR 2021;17:207-33. [DOI: 10.2174/1573394717999210120195208] [Reference Citation Analysis]
27 Li M, Tang Y, Guo L, Lei T, Deng Y, Wang L, Zhang Q, Li C. Antibiotic Resistance Characterization of Bacteria Isolated from Traditional Chinese Paocai. Curr Microbiol 2021. [PMID: 34390373 DOI: 10.1007/s00284-021-02629-z] [Reference Citation Analysis]
28 Khan AA, Sirsat AT, Singh H, Cash P. Microbiota and cancer: current understanding and mechanistic implications. Clin Transl Oncol 2021. [PMID: 34387847 DOI: 10.1007/s12094-021-02690-x] [Reference Citation Analysis]
29 Bhattacharjee MK, Bommareddy PK, DePass AL. A Water-Soluble Antibiotic in Rhubarb Stalk Shows an Unusual Pattern of Multiple Zones of Inhibition and Preferentially Kills Slow-Growing Bacteria. Antibiotics (Basel) 2021;10:951. [PMID: 34439001 DOI: 10.3390/antibiotics10080951] [Reference Citation Analysis]
30 Ebrahimzadeh S, Ahangari H, Soleimanian A, Hosseini K, Ebrahimi V, Ghasemnejad T, Soofiyani SR, Tarhriz V, Eyvazi S. Colorectal cancer treatment using bacteria: focus on molecular mechanisms. BMC Microbiol 2021;21:218. [PMID: 34281519 DOI: 10.1186/s12866-021-02274-3] [Reference Citation Analysis]
31 Sharma PC, Sharma D, Sharma A, Bhagat M, Ola M, Thakur VK, Bhardwaj JK, Goyal RK. Recent advances in microbial toxin-related strategies to combat cancer. Semin Cancer Biol 2021:S1044-579X(21)00201-7. [PMID: 34271147 DOI: 10.1016/j.semcancer.2021.07.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Sabo AA, Dudau M, Constantin GL, Pop TC, Geilfus CM, Naccarati A, Dragomir MP. Two Worlds Colliding: The Interplay Between Natural Compounds and Non-Coding Transcripts in Cancer Therapy. Front Pharmacol 2021;12:652074. [PMID: 34295245 DOI: 10.3389/fphar.2021.652074] [Reference Citation Analysis]
33 Zhu I, Haq Z, Ali MH, Chang PY, Zahid S, Mieler WF. APPLICATION OF ADJUNCTIVE TOPICAL MITOMYCIN-C IN SCLEROSTOMY REVISION FOR REFRACTORY IDIOPATHIC UVEAL EFFUSION SYNDROME. Retin Cases Brief Rep 2021;15:339-43. [PMID: 30614924 DOI: 10.1097/ICB.0000000000000840] [Reference Citation Analysis]
34 Singh V, Johansson P, Lin YL, Hammarsten O, Westerlund F. Shining light on single-strand lesions caused by the chemotherapy drug bleomycin. DNA Repair (Amst) 2021;105:103153. [PMID: 34119948 DOI: 10.1016/j.dnarep.2021.103153] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Sridhar K, Inbaraj BS, Chen BH. Recent developments on production, purification and biological activity of marine peptides. Food Res Int 2021;147:110468. [PMID: 34399466 DOI: 10.1016/j.foodres.2021.110468] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Diwan D, Cheng L, Usmani Z, Sharma M, Holden N, Willoughby N, Sangwan N, Baadhe RR, Liu C, Gupta VK. Microbial cancer therapeutics: A promising approach. Semin Cancer Biol 2021:S1044-579X(21)00131-0. [PMID: 33979677 DOI: 10.1016/j.semcancer.2021.05.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Mohamed MF, Wood SJ, Roy R, Reiser J, Kuzel TM, Shafikhani SH. Pseudomonas aeruginosa ExoT induces G1 cell cycle arrest in melanoma cells. Cell Microbiol 2021;23:e13339. [PMID: 33821556 DOI: 10.1111/cmi.13339] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Ahammad F, Alam R, Mahmud R, Akhter S, Talukder EK, Tonmoy AM, Fahim S, Al-Ghamdi K, Samad A, Qadri I. Pharmacoinformatics and molecular dynamics simulation-based phytochemical screening of neem plant (Azadiractha indica) against human cancer by targeting MCM7 protein. Brief Bioinform 2021:bbab098. [PMID: 33834183 DOI: 10.1093/bib/bbab098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
39 Chiu CF, Chiu SJ, Bai LY, Feng CH, Hu JL, Lin WY, Huang HY, Weng JR. A macrolide from Streptomyces sp. modulates apoptosis and autophagy through Mcl-1 downregulation in human breast cancer cells. Environ Toxicol 2021;36:1316-25. [PMID: 33713530 DOI: 10.1002/tox.23128] [Reference Citation Analysis]
40 Reissmann S, Filatova MP. New generation of cell‐penetrating peptides: Functionality and potential clinical application. J Pep Sci 2021;27. [DOI: 10.1002/psc.3300] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
41 Zhang QT, Liu ZD, Wang Z, Wang T, Wang N, Wang N, Zhang B, Zhao YF. Recent Advances in Small Peptides of Marine Origin in Cancer Therapy. Mar Drugs 2021;19:115. [PMID: 33669851 DOI: 10.3390/md19020115] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
42 Huang F, Shu Q, Qin Z, Tian J, Su Z, Huang Y, Gao M. Anticancer Actions of Azurin and Its Derived Peptide p28. Protein J 2020;39:182-9. [PMID: 32180097 DOI: 10.1007/s10930-020-09891-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Sawant SS, Patil SM, Gupta V, Kunda NK. Microbes as Medicines: Harnessing the Power of Bacteria in Advancing Cancer Treatment. Int J Mol Sci 2020;21:E7575. [PMID: 33066447 DOI: 10.3390/ijms21207575] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
44 Fiorentini C, Carlini F, Germinario EAP, Maroccia Z, Travaglione S, Fabbri A. Gut Microbiota and Colon Cancer: A Role for Bacterial Protein Toxins? Int J Mol Sci 2020;21:E6201. [PMID: 32867331 DOI: 10.3390/ijms21176201] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
45 Baindara P, Mandal SM. Bacteria and bacterial anticancer agents as a promising alternative for cancer therapeutics. Biochimie 2020;177:164-89. [PMID: 32827604 DOI: 10.1016/j.biochi.2020.07.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
46 Kapil S, Sharma V. d-Amino acids in antimicrobial peptides: a potential approach to treat and combat antimicrobial resistance. Can J Microbiol 2021;67:119-37. [PMID: 32783775 DOI: 10.1139/cjm-2020-0142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Yaghoubi A, Khazaei M, Avan A, Hasanian SM, Cho WC, Soleimanpour S. p28 Bacterial Peptide, as an Anticancer Agent. Front Oncol 2020;10:1303. [PMID: 32850408 DOI: 10.3389/fonc.2020.01303] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
48 Yaghoubi A, Khazaei M, Jalili S, Hasanian SM, Avan A, Soleimanpour S, Cho WC. Bacteria as a double-action sword in cancer. Biochim Biophys Acta Rev Cancer 2020;1874:188388. [PMID: 32589907 DOI: 10.1016/j.bbcan.2020.188388] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
49 Feng S, Luan X, Wang Y, Wang H, Zhang Z, Wang Y, Tian Z, Liu M, Xiao Y, Zhao Y, Zhou R, Zhang S. Eltrombopag is a potential target for drug intervention in SARS-CoV-2 spike protein. Infect Genet Evol 2020;85:104419. [PMID: 32540428 DOI: 10.1016/j.meegid.2020.104419] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
50 Aldarhami A, Felek A, Sharma V, Upton M. Purification and characterization of nisin P produced by a strain of Streptococcus gallolyticus. J Med Microbiol 2020;69:605-16. [PMID: 32125268 DOI: 10.1099/jmm.0.001170] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Wang Z, Yu W, Qiang Y, Xu L, Ma F, Ding P, Shi L, Chang W, Mei Y, Ma X. LukS-PV Inhibits Hepatocellular Carcinoma Progression by Downregulating HDAC2 Expression. Mol Ther Oncolytics 2020;17:547-61. [PMID: 32637573 DOI: 10.1016/j.omto.2020.05.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
52 Castillo RR, Lozano D, Vallet-Regí M. Mesoporous Silica Nanoparticles as Carriers for Therapeutic Biomolecules. Pharmaceutics 2020;12:E432. [PMID: 32392811 DOI: 10.3390/pharmaceutics12050432] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 10.5] [Reference Citation Analysis]
53 Ghasemi-Dehkordi P, Doosti A, Jami MS. The functions of azurin of Pseudomonas aeruginosa and human mammaglobin-A on proapoptotic and cell cycle regulatory genes expression in the MCF-7 breast cancer cell line. Saudi J Biol Sci 2020;27:2308-17. [PMID: 32884412 DOI: 10.1016/j.sjbs.2020.04.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Varas MA, Muñoz-Montecinos C, Kallens V, Simon V, Allende ML, Marcoleta AE, Lagos R. Exploiting Zebrafish Xenografts for Testing the in vivo Antitumorigenic Activity of Microcin E492 Against Human Colorectal Cancer Cells. Front Microbiol 2020;11:405. [PMID: 32265865 DOI: 10.3389/fmicb.2020.00405] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
55 Maksimov IV, Singh BP, Cherepanova EA, Burkhanova GF, Khairullin RM. Prospects and Applications of Lipopeptide-Producing Bacteria for Plant Protection (Review). Appl Biochem Microbiol 2020;56:15-28. [DOI: 10.1134/s0003683820010135] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
56 Arunmanee W, Ecoy GAU, Khine HEE, Duangkaew M, Prompetchara E, Chanvorachote P, Chaotham C. Colicin N Mediates Apoptosis and Suppresses Integrin-Modulated Survival in Human Lung Cancer Cells. Molecules 2020;25:E816. [PMID: 32069989 DOI: 10.3390/molecules25040816] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
57 Wang E, Sorolla MA, Krishnan PDG, Sorolla A. From Seabed to Bedside: A Review on Promising Marine Anticancer Compounds. Biomolecules 2020;10:E248. [PMID: 32041255 DOI: 10.3390/biom10020248] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 8.5] [Reference Citation Analysis]
58 Laliani G, Ghasemian Sorboni S, Lari R, Yaghoubi A, Soleimanpour S, Khazaei M, Hasanian SM, Avan A. Bacteria and cancer: Different sides of the same coin. Life Sci 2020;246:117398. [PMID: 32032647 DOI: 10.1016/j.lfs.2020.117398] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
59 Krześniak M, Zajkowicz A, Gdowicz-Kłosok A, Głowala-Kosińska M, Łasut-Szyszka B, Rusin M. Synergistic activation of p53 by actinomycin D and nutlin-3a is associated with the upregulation of crucial regulators and effectors of innate immunity. Cell Signal 2020;69:109552. [PMID: 32032660 DOI: 10.1016/j.cellsig.2020.109552] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
60 Ameer K, Chirom A, Paul A. Production and purification of anti-tubercular and anticancer protein from Staphylococcus hominis under mild stress condition of Mentha piperita L. J Pharm Biomed Anal 2020;182:113136. [PMID: 32035335 DOI: 10.1016/j.jpba.2020.113136] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Qiang Y, Ma F, Wang Z, Nie Z, Xu L, Ding P, Ma X. LukS-PV induces cell cycle arrest and apoptosis through p38/ERK MAPK signaling pathway in NSCLC cells. Biochem Biophys Res Commun 2020;521:846-52. [PMID: 31708104 DOI: 10.1016/j.bbrc.2019.10.181] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
62 Zhang D, He Y, Ye Y, Ma Y, Zhang P, Zhu H, Xu N, Liang S. Little Antimicrobial Peptides with Big Therapeutic Roles. Protein Pept Lett 2019;26:564-78. [PMID: 30799781 DOI: 10.2174/1573406415666190222141905] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
63 Rodrigues G, Silva GGO, Buccini DF, Duque HM, Dias SC, Franco OL. Bacterial Proteinaceous Compounds With Multiple Activities Toward Cancers and Microbial Infection. Front Microbiol 2019;10:1690. [PMID: 31447795 DOI: 10.3389/fmicb.2019.01690] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
64 Ghasemi-Dehkordi P, Doosti A, Jami MS. The concurrent effects of azurin and Mammaglobin-A genes in inhibition of breast cancer progression and immune system stimulation in cancerous BALB/c mice. 3 Biotech 2019;9:271. [PMID: 31245235 DOI: 10.1007/s13205-019-1804-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
65 Schaduangrat N, Nantasenamat C, Prachayasittikul V, Shoombuatong W. ACPred: A Computational Tool for the Prediction and Analysis of Anticancer Peptides. Molecules 2019;24:E1973. [PMID: 31121946 DOI: 10.3390/molecules24101973] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 17.7] [Reference Citation Analysis]
66 Ashu EE, Xu J, Yuan ZC. Bacteria in Cancer Therapeutics: A Framework for Effective Therapeutic Bacterial Screening and Identification. J Cancer 2019;10:1781-93. [PMID: 31205534 DOI: 10.7150/jca.31699] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
67 Janosch D, Dubbert S, Eiteljörge K, Diehl BWK, Sonnenborn U, Passchier LV, Wassenaar TM, von Bünau R. Anti-genotoxic and anti-mutagenic activity of Escherichia coli Nissle 1917 as assessed by in vitro tests. Benef Microbes 2019;10:449-61. [PMID: 30957533 DOI: 10.3920/BM2018.0113] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
68 Sereena MC, Sebastian D. Evaluation of Anticancer and Anti-hemolytic Activity of Azurin, a Novel Bacterial Protein from Pseudomonas aeruginosa SSj. Int J Pept Res Ther 2020;26:459-66. [DOI: 10.1007/s10989-019-09851-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Shoombuatong W, Schaduangrat N, Nantasenamat C. Unraveling the bioactivity of anticancer peptides as deduced from machine learning. EXCLI J 2018;17:734-52. [PMID: 30190664 DOI: 10.17179/excli2018-1447] [Cited by in F6Publishing: 27] [Reference Citation Analysis]